Law Offices of Todd M. Garber Announces Class Action Lawsuit Against AVEO Pharmaceuticals, Inc.

  Law Offices of Todd M. Garber Announces Class Action Lawsuit Against AVEO
  Pharmaceuticals, Inc.

Business Wire

LOS ANGELES -- June 12, 2013

The Law Offices of Todd M. Garber announces that a class action lawsuit has
been filed in the United States District Court for the District of
Massachusetts on behalf of a class (the “Class”) comprising all purchasers of
the securities of AVEO Pharmaceuticals, Inc. (“AVEO” or the “Company”)
(NASDAQ: AVEO) between January 3, 2012 and May 1, 2013, inclusive (the “Class
Period”).

AVEO engages in discovering, developing, and commercializing targeted cancer
therapies. The Complaint alleges that defendants issued materially false and
misleading statements throughout the Class Period regarding the Phase III
trial design and results for the Company’s drug Tivopath, or tivozanib, for
the treatment of advanced kidney cancer. Specifically, defendants
misrepresented or failed to disclose that: (1) the U.S. Food and Drug
Administration had recommended that the Company conduct an additional Phase
III trial due to adverse trends in the Company’s first Phase III trial; (2)
there was a 25% higher rate of death associated with tivozanib therapy
compared to the control drug, sorafenib; and (3) almost 90% of patients
studied in the single Phase III trial were enrolled from sites in Central and
Eastern Europe with inconsistent treatment patterns from those in the United
States.

If you are a member of the above-described Class, you may move the Court no
later than July 8, 2013 to serve as lead plaintiff; however, you must meet
certain legal requirements. To be a member of the Class you need not take any
action at this time, or you may retain counsel of your choice. If you have
information or would like to learn more about these claims, or if you
purchased AVEO stock prior to the Class Period and have any questions
concerning this announcement or your rights or interests with respect to these
matters, please contact Todd M. Garber, Esquire, of the Law Offices of Todd M.
Garber, by telephone at 213-700-7262 or by email to info@toddgarberlaw.com.

This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and ethical rules.

Contact:

Law Offices of Todd M. Garber
Todd M. Garber, Attorney at Law
Los Angeles, California
213-700-7262
info@toddgarberlaw.com
 
Press spacebar to pause and continue. Press esc to stop.